These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1423777)

  • 1. Effect of methotrexate treatment on the onset of autoimmune kidney disease in lupus mice.
    Mihara M; Katsume A; Takeda Y
    Chem Pharm Bull (Tokyo); 1992 Aug; 40(8):2177-81. PubMed ID: 1423777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel antifolate, MX-68, inhibits the development of autoimmune disease in MRL/lpr mice.
    Mihara M; Takagi N; Urakawa K; Moriya Y; Takeda Y
    Int Arch Allergy Immunol; 1997 Aug; 113(4):454-9. PubMed ID: 9250591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of several kinds of drugs on the development of autoimmunity in MRL/Mp-lpr/lpr mice; lack of correlation between the suppression of autoantibody production and prevention of autoimmune disease.
    Mihara M; Ohsugi Y
    J Pharmacobiodyn; 1989 Feb; 12(2):100-6. PubMed ID: 2526211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in the occurrence of hypertension among (NZB X NZW)F1, MRL-lpr, and BXSB mice with lupus nephritis.
    Rudofsky UH; Dilwith RL; Roths JB; Lawrence DA; Kelley VE; Magro AM
    Am J Pathol; 1984 Jul; 116(1):107-14. PubMed ID: 6377906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventive effect of a novel antifolate, MX-68, in murine systemic lupus erythematosus (SLE).
    Mihara M; Takagi N; Urakawa K; Moriya Y; Takeda Y
    Int J Immunopharmacol; 1997 Feb; 19(2):67-74. PubMed ID: 9278176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effect of the autoimmune Yaa and lpr genes on the acceleration of lupus-like syndrome in MRL/MpJ mice.
    Merino R; Shibata T; De Kossodo S; Izui S
    Eur J Immunol; 1989 Nov; 19(11):2131-7. PubMed ID: 2599002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of natural autoantibodies in MRL-lpr mice protects from lupus nephritis and improves survival.
    Mannoor K; Matejuk A; Xu Y; Beardall M; Chen C
    J Immunol; 2012 Apr; 188(8):3628-38. PubMed ID: 22407922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCR3 promotes the production of IgG1 autoantibodies but is not essential for the development of lupus nephritis in NZB/NZW mice.
    Moser K; Kalies K; Szyska M; Humrich JY; Amann K; Manz RA
    Arthritis Rheum; 2012 Apr; 64(4):1237-46. PubMed ID: 22006377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyclonal B cell activation arises from different mechanisms in lupus-prone (NZB x NZW)F1 and MRL/MpJ-lpr/lpr mice.
    Merino R; Iwamoto M; Fossati L; Izui S
    J Immunol; 1993 Dec; 151(11):6509-16. PubMed ID: 7902378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic reticuloendothelial system activation in autoimmune mice: differences between (NZB X NZW)F1 and MRL-lpr/lpr strains.
    Magilavy DB; Hundley TR; Steinberg AD; Katona IM
    Clin Immunol Immunopathol; 1987 Mar; 42(3):386-98. PubMed ID: 3030589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine models of systemic lupus erythematosus: B and T cell responses to spliceosomal ribonucleoproteins in MRL/Fas(lpr) and (NZB x NZW)F(1) lupus mice.
    Monneaux F; Dumortier H; Steiner G; Briand JP; Muller S
    Int Immunol; 2001 Sep; 13(9):1155-63. PubMed ID: 11526096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fc receptor-independent development of autoimmune glomerulonephritis in lupus-prone MRL/lpr mice.
    Matsumoto K; Watanabe N; Akikusa B; Kurasawa K; Matsumura R; Saito Y; Iwamoto I; Saito T
    Arthritis Rheum; 2003 Feb; 48(2):486-94. PubMed ID: 12571859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRL mice produce anti-Su autoantibody, a specificity associated with systemic lupus erythematosus.
    Treadwell EL; Cohen P; Williams D; O'Brien K; Volkman A; Eisenberg R
    J Immunol; 1993 Jan; 150(2):695-9. PubMed ID: 8419494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences between CD8+ T cells in lupus-prone (NZB x NZW) F1 mice and healthy (BALB/c x NZW) F1 mice may influence autoimmunity in the lupus model.
    Karpouzas GA; La Cava A; Ebling FM; Singh RR; Hahn BH
    Eur J Immunol; 2004 Sep; 34(9):2489-99. PubMed ID: 15307181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of thymectomy or androgen administration upon the autoimmune disease of MRL/Mp-lpr/lpr mice.
    Steinberg AD; Roths JB; Murphy ED; Steinberg RT; Raveche ES
    J Immunol; 1980 Aug; 125(2):871-3. PubMed ID: 7391583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of immunological effects of cholera toxin on autoimmune MRL/lpr and BXSB mice.
    Zhou NN; Nakai S; Oka M; Nagasawa H; Himeno K
    Microbiol Immunol; 1992; 36(7):745-56. PubMed ID: 1406377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of estrogen-induced autoantibodies to cardiolipin in non-autoimmune mice.
    Verthelyi D; Ansar Ahmed S
    J Autoimmun; 1997 Apr; 10(2):115-25. PubMed ID: 9185873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of castration and sex hormones on immune clearance and autoimmune disease in MRL/Mp-lpr/lpr and MRL/Mp-+/+ mice.
    Shear HL; Wofsy D; Talal N
    Clin Immunol Immunopathol; 1983 Mar; 26(3):361-9. PubMed ID: 6872348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined treatment of autoimmune MRL/Mp-lpr/lpr mice with cholera toxin plus irradiation. Combined treatment of autoimmune MRL/l mice.
    Fan JL; Himeno K; Hussain A; Nomoto K
    Biotherapy; 1989; 1(2):97-102. PubMed ID: 2641464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to tolerance induction is not prerequisite to development of murine SLE.
    Izui S; Masuda K
    J Immunol; 1984 Dec; 133(6):3010-4. PubMed ID: 6491280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.